Polish Pursuit: EUPATI Takes its Message to Warsaw
EUPATI announced that its second workshop will take place on April 2, 2014 at the Hotel InterContinental Warszawa, Poland.
The European Patients’ Academy on Therapeutic Innovation (EUPATI) has announced that its second workshop, “Reaching a Public Audience on Medicines Development,” will take place on April 2, 2014 at the Hotel InterContinental Warszawa, Poland.
The workshop has been designed to draw on EUPATI’s social research work involving patients and citizens across Europe, as well as to hear views from patient advocates and the public and to provide details about successful examples of information sharing. Among the attendees are likely to be representatives from stakeholder groups that have a role in the medicines development process, including patients, industry, academia, ethics committees, regulators, and medical professionals.
According to the organizers, “Breakout sessions will be used for brainstorming on the best ways to inform patients and citizens about medicines research and development. We want each workshop delegate to advise us on how EUPATI can meet the information needs of the patient community and provide information appropriately. Throughout the workshop you will have many opportunities to voice your opinions and share your thoughts. We strongly encourage open and active dialogues in Warsaw!”
EUPATI is funded by the Innovative Medicines Initiative, and aims to provide scientifically reliable, objective, comprehensive information to patients on medicines research and development. It seeks to increase the capacities and capabilities of well-informed patients and patient organizations to be effective advocates and advisors in medicines research.
Empowering Sites and Patients: The Impact of Personalized Support in Clinical Trials
November 26th 2024To meet the growing demands of clinical research, sponsors must prioritize comprehensive support models, such as clinical site ambassadors and patient journey coordinators, who can address operational challenges and improve site relationships, patient satisfaction, and overall trial efficiency.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
